ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank43
3Y CAGR-41.9%
5Y CAGR+11.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-41.9%/yr
vs +79.8%/yr prior
5Y CAGR
+11.0%/yr
Recent deceleration
Acceleration
-121.6pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $41.32M | -18.7% |
| 2024 | $50.82M | -28.4% |
| 2023 | $70.97M | -66.3% |
| 2022 | $210.52M | +250.5% |
| 2021 | $60.06M | +144.9% |
| 2020 | $24.52M | +145.8% |
| 2019 | $9.98M | -50.5% |
| 2018 | $20.16M | - |